Regulus Therapeutics Inc. (RGLS) Net Income (Loss) Attributable to Parent USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Regulus Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2024.
  • Regulus Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$8.47 M, a 18.6% decline year-over-year.
  • Regulus Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$31.4 M, a 9.13% decline year-over-year.
  • Regulus Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$30 M, a 6.05% decline from 2022.
  • Regulus Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$28.3 M, a 1.85% decline from 2021.
  • Regulus Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$27.8 M, a 76.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$31.4 M -$8.47 M -$1.33 M -18.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$30 M -$8.06 M -$1.27 M -18.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$28.8 M -$7.82 M -$273 K -3.62% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$28.5 M -$7.01 M +$245 K +3.38% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-09
Q1 2023 -$28.7 M -$7.14 M -$420 K -6.25% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$28.3 M -$6.8 M +$338 K +4.74% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$28.7 M -$7.55 M +$1.08 M +12.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$29.7 M -$7.26 M -$1.22 M -20.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$28.5 M -$6.72 M -$706 K -11.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$27.8 M -$7.13 M -$5.81 M -440% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$22 M -$8.63 M -$7.1 M -466% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$14.9 M -$6.03 M +$913 K +13.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$15.8 M -$6.01 M -$76 K -1.28% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$15.7 M -$1.32 M +$3.57 M +73% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-09
Q3 2020 -$19.3 M -$1.52 M +$3.9 M +71.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$23.2 M -$6.95 M -$1.93 M -38.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$21.3 M -$5.94 M -$2.68 M -82.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$18.6 M -$4.89 M +$3.67 M +42.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$22.3 M -$5.42 M +$4.85 M +47.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-09
Q2 2019 -$27.1 M -$5.02 M +$8.83 M +63.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-09
Q1 2019 -$35.9 M -$3.26 M +$12.8 M +79.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-09
Q4 2018 -$48.7 M -$8.56 M +$5.89 M +40.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$54.6 M -$10.3 M +$5.56 M +35.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$60.1 M -$13.8 M +$7.76 M +35.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$67.9 M -$16 M +$4 M +20% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$71.9 M -$14.4 M +$5.57 M +27.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$77.5 M -$15.8 M +$3.69 M +18.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$81.2 M -$21.6 M -$518 K -2.46% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$80.7 M -$20 M +$1.19 M +5.59% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$81.8 M -$20 M -$12.8 M -177% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$69 M -$19.5 M -$6.52 M -50.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$62.5 M -$21.1 M -$55 K -0.26% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$62.5 M -$21.2 M -$6.72 M -46.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$55.7 M -$7.23 M +$14.9 M +67.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-03
Q3 2015 -$70.7 M -$13 M -$3.2 M -32.7% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-03
Q2 2015 -$67.5 M -$21 M -$9.06 M -75.7% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-03
Q1 2015 -$58.4 M -$14.5 M -$1.75 M -13.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-03
Q4 2014 -$56.7 M -$22.2 M -$20.2 M -1050% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-23
Q3 2014 -$36.4 M -$9.8 M -$7.63 M -353% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-23
Q2 2014 -$28.8 M -$12 M -$4.63 M -62.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-23
Q1 2014 -$24.2 M -$12.7 M -$5.51 M -76.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-23
Q4 2013 -$18.7 M -$1.93 M +$4.95 M +72% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-19
Q3 2013 -$23.6 M -$2.16 M +$3.52 M +61.9% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-19
Q2 2013 -$27.1 M -$7.35 M -$4.75 M -183% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-19
Q1 2013 -$22.4 M -$7.23 M -$4.98 M -222% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-19
Q4 2012 -$17.4 M -$6.88 M -$4.86 M -241% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 -$12.5 M -$5.69 M -$4.64 M -444% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-28
Q2 2012 -$7.91 M -$2.6 M -$346 K -15.4% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-28
Q1 2012 -$7.56 M -$2.25 M +$41 K +1.79% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-28
Q4 2011 -$7.6 M -$2.02 M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-19
Q3 2011 -$1.05 M Jul 1, 2011 Sep 30, 2011 10-K 2013-02-19
Q2 2011 -$2.25 M Apr 1, 2011 Jun 30, 2011 10-K 2013-02-19
Q1 2011 -$2.29 M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.